{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:38:31Z","timestamp":1793813911254,"version":"4.6.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background and Aim<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) progresses with A\u03b2 plaque deposition and neuroinflammation. Given the complexity of AD pathology, single-target therapies have frequently failed in clinical trials. We hypothesized that a multitarget approach could yield better therapeutic outcomes. To this end, we identified isobavachalcone (IBC), a natural compound with dual pharmacological activity in reducing A\u03b2 plaques and neuroinflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Experimental Procedure<\/jats:title><jats:p>Primary astrocytes were isolated from 3 to 4 days old C57BL\/6J mice pups for <jats:italic>in-vitro<\/jats:italic> assays, while <jats:italic>in-vivo<\/jats:italic> studies were conducted on 5x-FAD mice. Protein alterations were evaluated using ELISA, western blotting, immunocytochemistry, and immunohistochemistry. Behavioral analyses included the radial arm maze, open field, and rotarod tests. Data from all <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experiments were analyzed by using one-way ANOVA and <jats:italic>post-hoc<\/jats:italic> Bonferroni tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:italic>In-vitro<\/jats:italic> analyses in astrocytes demonstrated that IBC at 5 and 10\u00a0\u03bcM concentrations induce AMPK phosphorylation through CAMKK2, promoting autophagy and inhibiting the NLRP3 inflammasome in primary astrocytes. IBC-treated astrocytes exhibited significant clearance of extracellular amyloid beta. Mechanistic studies highlighted autophagy as a key factor in reducing both NLRP3 inflammasome activity and A\u03b2 levels. Two months of treatment of 5x-FAD mice with IBC at 25 and 50\u00a0mg\/kg significantly improved cognitive functions, as evidenced by enhanced memory and motor performance in behavioral tests. Subsequent brain tissue analysis revealed that IBC upregulated autophagic proteins to reduce the brain\u2019s amyloid beta levels, resulting in decreased expression of neuroinflammation markers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>IBC effectively ameliorates AD pathology through autophagy-mediated clearance of A\u03b2 and suppressing neuroinflammation in 5x-FAD mice.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1525364","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T09:41:35Z","timestamp":1742463695000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Isobavachalcone ameliorates Alzheimer disease pathology by autophagy-mediated clearance of amyloid beta and inhibition of NLRP3 inflammasome in primary astrocytes and 5x-FAD mice"],"prefix":"10.3389","volume":"16","author":[{"given":"Dilpreet","family":"Kour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Khajuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuhu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Mudassir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Wazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ramajayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghapal D.","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zabeer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ncl.2023.01.001","article-title":"Sex differences in Alzheimer's disease","volume":"41","author":"Aggarwal","year":"2023","journal-title":"Neurol. Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0197-4580(00)00124-x","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. aging"},{"key":"B3","doi-asserted-by":"publisher","first-page":"13547","DOI":"10.1073\/pnas.93.24.13547","article-title":"Cognitive and neurobiologic markers of early Alzheimer disease","volume":"93","author":"Albert","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10572","DOI":"10.3390\/ijms231810572","article-title":"Glial cell-mediated neuroinflammation in Alzheimer's disease","volume":"23","author":"Al-Ghraiybah","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","article-title":"Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer's disease therapeutics","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","article-title":"Alzheimer's disease drug development pipeline: 2017","volume":"3","author":"Cummings","year":"2017","journal-title":"Alzheimer's & dementia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimer's Res. & Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0281003","DOI":"10.1371\/journal.pone.0281003","article-title":"Preclinical trials in Alzheimer's disease: sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice","volume":"18","author":"Faisal","year":"2023","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci. data"},{"key":"B11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/nan.12338","article-title":"Review: astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role","volume":"43","author":"Garwood","year":"2017","journal-title":"Neuropathology Appl. Neurobiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fnmol.2017.00427","article-title":"Involvement of astrocytes in Alzheimer's disease from a neuroinflammatory and oxidative stress perspective","volume":"10","author":"Gonzalez-Reyes","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2210766119","DOI":"10.1073\/pnas.2210766119","article-title":"Early diagnosis and treatment of Alzheimer\u2019s disease by targeting toxic soluble A\u03b2 oligomers","volume":"119","author":"Habashi","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-v","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1074\/jbc.M110.202911","article-title":"Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation","volume":"286","author":"Harris","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e99430","DOI":"10.15252\/embj.201899430","article-title":"Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP3","volume":"38","author":"Houtman","year":"2019","journal-title":"EMBO J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. & Mol. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1196\/annals.1332.006","article-title":"Microglia as a potential bridge between the amyloid beta-peptide and tau","volume":"1035","author":"Kitazawa","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B24","article-title":"Alzheimer disease. StatPearls. Treasure island (FL) ineligible companies","volume-title":"Disclosure: jaskirat Sidhu declares no relevant financial relationships with ineligible companies. Disclosure: amandeep Goyal declares no relevant financial relationships with ineligible companies. Disclosure: jack Tsao declares no relevant financial relationships with ineligible companies","author":"Kumar","year":"2023"},{"key":"B25","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","article-title":"Faulty autolysosome acidification in Alzheimer\u2019s disease mouse models induces autophagic build-up of A\u03b2 in neurons, yielding senile plaques","volume":"25","author":"Lee","year":"2022","journal-title":"Nat. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"845185","DOI":"10.3389\/fphar.2022.845185","article-title":"The role of NLRP3 inflammasome in Alzheimer's disease and potential therapeutic targets","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/jnc.14945","article-title":"Soluble A\u03b2 oligomers and protofibrils induce NLRP3 inflammasome activation in microglia","volume":"155","author":"Luciunaite","year":"2020","journal-title":"J. Neurochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/15548627.2019.1596488","article-title":"Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model","volume":"16","author":"Luo","year":"2020","journal-title":"Autophagy"},{"key":"B30","doi-asserted-by":"publisher","first-page":"106013","DOI":"10.1016\/j.biocel.2021.106013","article-title":"Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics","volume":"136","author":"Mishra","year":"2021","journal-title":"Int. J. Biochem. & Cell Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.celrep.2013.08.042","article-title":"A\u03b2 secretion and plaque formation depend on autophagy","volume":"5","author":"Nilsson","year":"2013","journal-title":"Cell Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/bies.201400002","article-title":"Dual roles for autophagy: degradation and secretion of Alzheimer's disease A\u03b2 peptide","volume":"36","author":"Nilsson","year":"2014","journal-title":"Bioessays"},{"key":"B33","doi-asserted-by":"publisher","first-page":"800338","DOI":"10.3389\/fneur.2022.800338","article-title":"Locomotor adaptation deficits in older individuals with cognitive impairments: a pilot study","volume":"13","author":"Pottorf","year":"2022","journal-title":"Front. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer's disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimer's Dis. JAD."},{"key":"B35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/ars.2013.5347","article-title":"Regulation where autophagy intersects the inflammasome","volume":"20","author":"Rodgers","year":"2014","journal-title":"Antioxidants & Redox Signal."},{"key":"B36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","article-title":"The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease","volume":"11","author":"Saresella","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"B37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni.2215","article-title":"Activation of autophagy by inflammatory signals limits IL-1\u03b2 production by targeting ubiquitinated inflammasomes for destruction","volume":"13","author":"Shi","year":"2012","journal-title":"Nat. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using effect size-or why the P value is not enough","volume":"4","author":"Sullivan","year":"2012","journal-title":"J. Grad. Med. Educ."},{"key":"B42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/nejmoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-210268","article-title":"NLRP3 inflammasome: a starring role in amyloid-\u03b2- and tau-driven pathological events in Alzheimer's disease","volume":"83","author":"Van Zeller","year":"2021","journal-title":"J. Alzheimer's Dis. JAD."},{"key":"B44","doi-asserted-by":"publisher","first-page":"105483","DOI":"10.1016\/j.phrs.2021.105483","article-title":"Pharmacological review of isobavachalcone, a naturally occurring chalcone","volume":"165","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1080\/15548627.2021.1872187","article-title":"Crocetin promotes clearance of amyloid-\u03b2 by inducing autophagy via the STK11\/LKB1-mediated AMPK pathway","volume":"17","author":"Wani","year":"2021","journal-title":"Autophagy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1080\/15548627.2019.1596476","article-title":"Alborixin clears amyloid-\u03b2 by inducing autophagy through PTEN-mediated inhibition of the AKT pathway","volume":"15","author":"Wani","year":"2019","journal-title":"Autophagy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fgene.2014.00088","article-title":"Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models","volume":"5","author":"Webster","year":"2014","journal-title":"Front. Genet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"13767","DOI":"10.1021\/acs.jafc.9b05947","article-title":"Eicosapentaenoic acid-enriched phosphatidylcholine mitigated a\u03b21-42-induced neurotoxicity via autophagy-inflammasome pathway","volume":"67","author":"Wen","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.neurobiolaging.2013.05.018","article-title":"Differential pathways for interleukin-1\u03b2 production activated by chromogranin A and amyloid \u03b2 in microglia","volume":"34","author":"Wu","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/biomedicines7040097","article-title":"Reasons for failed trials of disease-modifying treatments for alzheimer disease and their contribution in recent research","volume":"7","author":"Yiannopoulou","year":"2019","journal-title":"Biomedicines"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1525364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T09:41:40Z","timestamp":1742463700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1525364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":50,"alternative-id":["10.3389\/fphar.2025.1525364"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1525364","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"article-number":"1525364"}}